388 related articles for article (PubMed ID: 24247300)
1. Low-dose dopamine or low-dose nesiritide in acute heart failure with renal dysfunction: the ROSE acute heart failure randomized trial.
Chen HH; Anstrom KJ; Givertz MM; Stevenson LW; Semigran MJ; Goldsmith SR; Bart BA; Bull DA; Stehlik J; LeWinter MM; Konstam MA; Huggins GS; Rouleau JL; O'Meara E; Tang WH; Starling RC; Butler J; Deswal A; Felker GM; O'Connor CM; Bonita RE; Margulies KB; Cappola TP; Ofili EO; Mann DL; Dávila-Román VG; McNulty SE; Borlaug BA; Velazquez EJ; Lee KL; Shah MR; Hernandez AF; Braunwald E; Redfield MM;
JAMA; 2013 Dec; 310(23):2533-43. PubMed ID: 24247300
[TBL] [Abstract][Full Text] [Related]
2. Differential Response to Low-Dose Dopamine or Low-Dose Nesiritide in Acute Heart Failure With Reduced or Preserved Ejection Fraction: Results From the ROSE AHF Trial (Renal Optimization Strategies Evaluation in Acute Heart Failure).
Wan SH; Stevens SR; Borlaug BA; Anstrom KJ; Deswal A; Felker GM; Givertz MM; Bart BA; Tang WH; Redfield MM; Chen HH
Circ Heart Fail; 2016 Aug; 9(8):. PubMed ID: 27512103
[TBL] [Abstract][Full Text] [Related]
3. Nesiritide does not improve renal function in patients with chronic heart failure and worsening serum creatinine.
Wang DJ; Dowling TC; Meadows D; Ayala T; Marshall J; Minshall S; Greenberg N; Thattassery E; Fisher ML; Rao K; Gottlieb SS
Circulation; 2004 Sep; 110(12):1620-5. PubMed ID: 15337695
[TBL] [Abstract][Full Text] [Related]
4. Is there still a role for low-dose dopamine use in acute heart failure?
Torres-Courchoud I; Chen HH
Curr Opin Crit Care; 2014 Oct; 20(5):467-71. PubMed ID: 25137402
[TBL] [Abstract][Full Text] [Related]
5. Effects of standard heart failure therapy and concomitant treatment with intravenous furosemide or inotropes (dobutamine, dopamine, and/or milrinone) on renal function and mortality in patients treated with nesiritide.
Kurien S; Warfield KT; Wood CM; Miller WL
Am J Cardiol; 2006 Dec; 98(12):1627-30. PubMed ID: 17145223
[TBL] [Abstract][Full Text] [Related]
6. Dopamine vs nesiritide for acute heart failure with renal dysfunction.
Kumar S
JAMA; 2014 Apr; 311(15):1565. PubMed ID: 24737371
[No Abstract] [Full Text] [Related]
7. Dopamine vs nesiritide for acute heart failure with renal dysfunction--reply.
Chen HH; Redfield MM
JAMA; 2014 Apr; 311(15):1565-6. PubMed ID: 24737372
[No Abstract] [Full Text] [Related]
8. Effect of nesiritide in patients with acute decompensated heart failure.
O'Connor CM; Starling RC; Hernandez AF; Armstrong PW; Dickstein K; Hasselblad V; Heizer GM; Komajda M; Massie BM; McMurray JJ; Nieminen MS; Reist CJ; Rouleau JL; Swedberg K; Adams KF; Anker SD; Atar D; Battler A; Botero R; Bohidar NR; Butler J; Clausell N; Corbalán R; Costanzo MR; Dahlstrom U; Deckelbaum LI; Diaz R; Dunlap ME; Ezekowitz JA; Feldman D; Felker GM; Fonarow GC; Gennevois D; Gottlieb SS; Hill JA; Hollander JE; Howlett JG; Hudson MP; Kociol RD; Krum H; Laucevicius A; Levy WC; Méndez GF; Metra M; Mittal S; Oh BH; Pereira NL; Ponikowski P; Tang WH; Tanomsup S; Teerlink JR; Triposkiadis F; Troughton RW; Voors AA; Whellan DJ; Zannad F; Califf RM
N Engl J Med; 2011 Jul; 365(1):32-43. PubMed ID: 21732835
[TBL] [Abstract][Full Text] [Related]
9. The effects of nesiritide on renal function and diuretic responsiveness in acutely decompensated heart failure patients with renal dysfunction.
Owan TE; Chen HH; Frantz RP; Karon BL; Miller WL; Rodeheffer RJ; Hodge DO; Burnett JC; Redfield MM
J Card Fail; 2008 May; 14(4):267-75. PubMed ID: 18474338
[TBL] [Abstract][Full Text] [Related]
10. Impact of nesiritide on renal function in patients with acute decompensated heart failure and pre-existing renal dysfunction a randomized, double-blind, placebo-controlled clinical trial.
Witteles RM; Kao D; Christopherson D; Matsuda K; Vagelos RH; Schreiber D; Fowler MB
J Am Coll Cardiol; 2007 Nov; 50(19):1835-40. PubMed ID: 17980248
[TBL] [Abstract][Full Text] [Related]
11. Low dose nesiritide and the preservation of renal function in patients with renal dysfunction undergoing cardiopulmonary-bypass surgery: a double-blind placebo-controlled pilot study.
Chen HH; Sundt TM; Cook DJ; Heublein DM; Burnett JC
Circulation; 2007 Sep; 116(11 Suppl):I134-8. PubMed ID: 17846293
[TBL] [Abstract][Full Text] [Related]
12. Safety and efficacy of outpatient nesiritide in patients with advanced heart failure: results of the Second Follow-Up Serial Infusions of Nesiritide (FUSION II) trial.
Yancy CW; Krum H; Massie BM; Silver MA; Stevenson LW; Cheng M; Kim SS; Evans R;
Circ Heart Fail; 2008 May; 1(1):9-16. PubMed ID: 19808265
[TBL] [Abstract][Full Text] [Related]
13. Comparative assessment of short-term adverse events in acute heart failure with cystatin C and other estimates of renal function: results from the ASCEND-HF trial.
Tang WHW; Dupont M; Hernandez AF; Voors AA; Hsu AP; Felker GM; Butler J; Metra M; Anker SD; Troughton RW; Gottlieb SS; McMurray JJ; Armstrong PW; Massie BM; Califf RM; O'Connor CM; Starling RC
JACC Heart Fail; 2015 Jan; 3(1):40-49. PubMed ID: 25453534
[TBL] [Abstract][Full Text] [Related]
14. ROSE-AHF and lessons learned.
Jain AK; Chen HH
Curr Heart Fail Rep; 2014 Sep; 11(3):260-5. PubMed ID: 24966060
[TBL] [Abstract][Full Text] [Related]
15. Nonhypotensive low-dose nesiritide has differential renal effects compared with standard-dose nesiritide in patients with acute decompensated heart failure and renal dysfunction.
Riter HG; Redfield MM; Burnett JC; Chen HH
J Am Coll Cardiol; 2006 Jun; 47(11):2334-5. PubMed ID: 16750705
[No Abstract] [Full Text] [Related]
16. Assessment of dyspnea in acute decompensated heart failure: insights from ASCEND-HF (Acute Study of Clinical Effectiveness of Nesiritide in Decompensated Heart Failure) on the contributions of peak expiratory flow.
Ezekowitz JA; Hernandez AF; O'Connor CM; Starling RC; Proulx G; Weiss MH; Bakal JA; Califf RM; McMurray JJ; Armstrong PW
J Am Coll Cardiol; 2012 Apr; 59(16):1441-8. PubMed ID: 22497823
[TBL] [Abstract][Full Text] [Related]
17. Prophylactic nesiritide does not prevent dialysis or all-cause mortality in patients undergoing high-risk cardiac surgery.
Ejaz AA; Martin TD; Johnson RJ; Winterstein AG; Klodell CT; Hess PJ; Ali AK; Whidden EM; Staples NL; Alexander JA; House-Fancher MA; Beaver TM
J Thorac Cardiovasc Surg; 2009 Oct; 138(4):959-64. PubMed ID: 19660420
[TBL] [Abstract][Full Text] [Related]
18. Lower urine sodium predicts longer length of stay in acute heart failure patients: Insights from the ROSE AHF trial.
Cunningham JW; Sun JL; Mc Causland FR; Ly S; Anstrom KJ; Lindenfeld J; Givertz MM; Stevenson LW; Lakdawala NK
Clin Cardiol; 2020 Jan; 43(1):43-49. PubMed ID: 31721249
[TBL] [Abstract][Full Text] [Related]
19. Low-dose nesiritide improves renal function in heart failure patients following acute myocardial infarction.
Zhao Q; Wu TG; Lin Y; Li B; Luo JY; Wang LX
Heart Vessels; 2010 Mar; 25(2):97-103. PubMed ID: 20339970
[TBL] [Abstract][Full Text] [Related]
20. Intravenous nesiritide vs nitroglycerin for treatment of decompensated congestive heart failure: a randomized controlled trial.
Publication Committee for the VMAC Investigators (Vasodilatation in the Management of Acute CHF)
JAMA; 2002 Mar; 287(12):1531-40. PubMed ID: 11911755
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
